Companion Diagnostics MarketThe global market for companion diagnostics is set for exponential growth, projected to expand from USD 5,700.5 million in 2024 to USD 11,682.8 million by 2035, registering ...

One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual ...

A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an alternative to surgeries and GLP-1 drugs.

For these people, a liquid potassium supplement can be advantageous. Liquid potassium supplements are a convenient way to increase your potassium intake and maintain healthy levels of this crucial ...

We look at what to expect from Trump’s pharma tariffs and what it could mean for India, a major medicine exporter, and America’s other trade partners. More from Explainers Tahawwur Rana’s extradition: ...

Clute, Howard M. — Professor of Surgery, Boston University School of Medicine. For record and address of author see "This Week's Issue," page 742.

The days of affordable prescription drugs —generics included — may soon come to an end thanks to President Trump’s aggressive tariffs and the global trade war they are inciting.

"We work on a daily basis to make sure that we have the medicine supply this country needs." Sir Keir Starmer had been seeking to secure an exemption for the UK from Mr Trump's punitive tariffs.

an innovative liquid biopsy test being deployed globally with the support of AstraZeneca, will be made available as a Precision for Medicine service for biopharma clients. Data generated by this ...

This is crucial for precision medicine efforts in oncology, rare diseases, and genetic disorders, where understanding the specific genomic characteristics of each patient may enable more targeted ...

Additionally, MSK-ACCESS® powered with SOPHiA DDMTM, an innovative liquid biopsy test being deployed globally with the support of AstraZeneca, will be made available as a Precision for Medicine ...